These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The influence of geranylgeraniol on human oral keratinocytes after bisphosphonate treatment: An in vitro study. Pabst AM, Krüger M, Ziebart T, Jacobs C, Sagheb K, Walter C. J Craniomaxillofac Surg; 2015 Jun; 43(5):688-95. PubMed ID: 25913629 [Abstract] [Full Text] [Related]
8. The influence of geranylgeraniol on microvessel sprouting after bisphosphonate substitution in an in vitro 3D-angiogenesis assay. Pabst AM, Krüger M, Sagheb K, Ziebart T, Jacobs C, Blatt S, Goetze E, Walter C. Clin Oral Investig; 2017 Apr; 21(3):771-778. PubMed ID: 27170294 [Abstract] [Full Text] [Related]
9. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts. Zafar S, Coates DE, Cullinan MP, Drummond BK, Milne T, Seymour GJ. J Oral Pathol Med; 2014 Oct; 43(9):711-21. PubMed ID: 24762323 [Abstract] [Full Text] [Related]
10. Comments on Novel Therapy to Reverse the Cellular Effects of Bisphosphonates on Primary Human Oral Fibroblasts by Cozin M et al (2011). Ziebart T, Walter C. J Oral Maxillofac Surg; 2012 Jan; 70(1):3. PubMed ID: 22182654 [No Abstract] [Full Text] [Related]
11. Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Scheper MA, Badros A, Chaisuparat R, Cullen KJ, Meiller TF. Br J Haematol; 2009 Mar; 144(5):667-76. PubMed ID: 19036117 [Abstract] [Full Text] [Related]
12. Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T. Clin Oral Investig; 2010 Feb; 14(1):35-41. PubMed ID: 19294435 [Abstract] [Full Text] [Related]
13. Geranylgeraniol - a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw. Ziebart T, Koch F, Klein MO, Guth J, Adler J, Pabst A, Al-Nawas B, Walter C. Oral Oncol; 2011 Mar; 47(3):195-201. PubMed ID: 21247791 [Abstract] [Full Text] [Related]
14. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells. Anitua E, Zalduendo M, Troya M, Orive G. Clin Oral Investig; 2016 Apr; 20(3):513-21. PubMed ID: 26201455 [Abstract] [Full Text] [Related]
15. Lysophosphatidic acid modulates the regenerative responses of human gingival fibroblasts and enhances the actions of platelet-derived growth factor. Cerutis DR, Dreyer A, Cordini F, McVaney TP, Mattson JS, Parrish LC, Romito L, Huebner GR, Jabro M. J Periodontol; 2004 Feb; 75(2):297-305. PubMed ID: 15068119 [Abstract] [Full Text] [Related]
16. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. Wessel JH, Dodson TB, Zavras AI. J Oral Maxillofac Surg; 2008 Apr; 66(4):625-31. PubMed ID: 18355585 [Abstract] [Full Text] [Related]
19. The effects of platelet-derived growth factor-BB on periodontal cells in an in vitro wound model. Mumford JH, Carnes DL, Cochran DL, Oates TW. J Periodontol; 2001 Mar; 72(3):331-40. PubMed ID: 11327060 [Abstract] [Full Text] [Related]
20. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G. Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788 [Abstract] [Full Text] [Related] Page: [Next] [New Search]